Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Med Tr Prom Ekol ; (3): 36-40, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15124394

RESUMO

The article deals with consequences seen in track driver after prolonged exposure to radiation caused by "lost" gamma-source (cesium-137) that long remained in receptacle of the vehicle's left door. Radiation dose averaged 8 Gy. The authors presented clinical manifestations, changes in peripheral blood and bone marrow, cytogenetic data by progression of radiation hemopoiesis hypoplasy to myelodysplastic syndrome and to acute leukaemia.


Assuntos
Condução de Veículo , Césio/efeitos adversos , Raios gama/efeitos adversos , Leucemia/etiologia , Doenças Profissionais/etiologia , Lesões por Radiação/complicações , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença Crônica , Evolução Fatal , Feminino , Encefalopatia Hepática , Humanos , Masculino , Pessoa de Meia-Idade
2.
Gematol Transfuziol ; 41(1): 6-9, 1996.
Artigo em Russo | MEDLINE | ID: mdl-8641585

RESUMO

The success in acute myeloblastic leukemia (AML) treatment for the last 10 years has been referred to growing intensity of chemotherapy. The efficacy of treatment has been assessed in 56 patients under 60 years of age. Double induction of remission according to the scheme TAD-9 (2-day administration of cytosar) and consolidation by large-dose cytosar (1 g/m2) with rubomycin have increased the frequency of 2-year recurrence-free running from 13 to 35%. Resistance to treatment was absent. Maintenance prolonged total and recurrence-free survival. Mycosis and hepatitis were factors responsible for inadequate intensity of chemotherapy. These need more advanced prevention. The intensive double induction and consolidation did not raise general toxicity and immediate lethality compared to standard regimens which proved inferior to the proposed treatment.


Assuntos
Antineoplásicos/uso terapêutico , Leucemia Mieloide Aguda/tratamento farmacológico , Adulto , Feminino , Humanos , Masculino , Indução de Remissão/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...